ExploreWatchlistsPricing
  1. JP-listed companies
  2. MEDIPAL HOLDINGS CORPORATION
  3. Financials
  4. Cash and cash equivalents

MEDIPAL HOLDINGS CORPORATION (7459)

Market cap
¥573.6B
P/E ratio
13.7x
Medipal Holdings distributes pharmaceuticals, medical devices, cosmetics, daily necessities, and veterinary products through 34 subsidiaries across Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 202649,198-81.18%
Mar 31, 2025261,407+13.58%
Mar 31, 2024230,154+18.01%
Mar 31, 2023195,031-19.79%
Mar 31, 2022243,150+9.16%
Mar 31, 2021222,747+7.32%
Mar 31, 2020207,545-2.57%
Mar 31, 2019213,025+4.66%
Mar 31, 2018203,546+23.16%
Mar 31, 2017165,267-1.86%
Mar 31, 2016168,393-7.28%
Mar 31, 2015181,606

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat